| Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA internal medicine 181 (1), 24-31, 2021 | 793 | 2021 |
| Clinical aspects of uncomplicated and severe malaria A Bartoloni, L Zammarchi Mediterranean journal of hematology and infectious diseases 4 (1), e2012026, 2012 | 598 | 2012 |
| Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, ... The Journal of clinical investigation 130 (9), 4694-4703, 2020 | 568 | 2020 |
| Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications L Zammarchi, G Stella, A Mantella, D Bartolozzi, D Tappe, S Günther, ... Journal of Clinical Virology 63, 32-35, 2015 | 286 | 2015 |
| An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014 G Venturi, L Zammarchi, C Fortuna, E Benedetti, C Fiorentini, M Trotta, ... Eurosurveillance 21, 1-4, 2016 | 276 | 2016 |
| Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase D Tappe, JV Pérez-Girón, L Zammarchi, J Rissland, DF Ferreira, ... Medical microbiology and immunology 205, 269-273, 2016 | 238 | 2016 |
| Zika virus infection in a traveller returning to Europe from Brazil, March 2015 L Zammarchi, D Tappe, C Fortuna, ME Remoli, S Günther, G Venturi, ... Eurosurveillance 20 (23), 21153, 2015 | 203 | 2015 |
| Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority … D Buonfrate, J Salas-Coronas, J Muñoz, BT Maruri, P Rodari, F Castelli, ... The Lancet infectious diseases 19 (11), 1181-1190, 2019 | 181 | 2019 |
| Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis E Bruno, A Bartoloni, L Zammarchi, M Strohmeyer, F Bartalesi, JA Bustos, ... PLoS neglected tropical diseases 7 (10), e2480, 2013 | 168 | 2013 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 152 | 2020 |
| Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990–2011 L Zammarchi, M Strohmeyer, F Bartalesi, E Bruno, J Muñoz, D Buonfrate, ... PloS one 8 (7), e69537, 2013 | 138 | 2013 |
| Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries A Requena-Méndez, D Buonfrate, J Gomez-Junyent, L Zammarchi, ... The American journal of tropical medicine and hygiene 97 (3), 645, 2017 | 137 | 2017 |
| First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 A Mazzoni, N Di Lauria, L Maggi, L Salvati, A Vanni, M Capone, ... The Journal of clinical investigation 131 (12), 2021 | 131 | 2021 |
| Schistosomiasis in European travelers and migrants: analysis of 14 years TropNet surveillance data T Lingscheid, F Kurth, J Clerinx, S Marocco, B Trevino, M Schunk, ... The American journal of tropical medicine and hygiene 97 (2), 567, 2017 | 109 | 2017 |
| Accuracy of parasitological and immunological tests for the screening of human schistosomiasis in immigrants and refugees from African countries: An approach with Latent Class … A Beltrame, M Guerriero, A Angheben, F Gobbi, A Requena-Mendez, ... PLoS Neglected Tropical Diseases 11 (6), e0005593, 2017 | 102 | 2017 |
| RCT-TCZ-COVID-19 Study Group. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA Intern Med 181 (1), 24-31, 2021 | 100 | 2021 |
| A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries L Zammarchi, G Casadei, M Strohmeyer, F Bartalesi, C Liendo, A Matteelli, ... BMC health services research 15, 1-11, 2015 | 85 | 2015 |
| Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study AM Vannucchi, B Sordi, A Morettini, C Nozzoli, L Poggesi, F Pieralli, ... Leukemia 35 (4), 1121-1133, 2021 | 82 | 2021 |
| Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients A Mazzoni, L Maggi, M Capone, M Spinicci, L Salvati, MG Colao, A Vanni, ... European Journal of Immunology 50 (12), 2013-2024, 2020 | 74 | 2020 |
| Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 F Lagi, M Piccica, L Graziani, I Vellere, A Botta, M Tilli, L Ottino, B Borchi, ... Eurosurveillance 25 (17), 2000556, 2020 | 69 | 2020 |
Zeno BisoffiCentro per le Malattie tropicali, Ospedale Sacro Cuore - Don Calabria, Negrar (Verona), Italyยืนยันอีเมลแล้วที่ sacrocuore.it